Viatris Inc (NASDAQ:VTRS)

9.63
BATS BZX Real-Time Price
As of 2:31pm ET
 +0.07 / +0.73%
Today’s Change
8.42
Today|||52-Week Range
12.40
-13.52%
Year-to-Date
Which Is the Better Dividend Stock: Viatris or Apple?
8:00am / MotleyFool.com - Paid Partner Content
Use These 3 Strategies to Make $1,000 in Passive Income Per Year
Mar 23 / MotleyFool.com - Paid Partner Content
Why Is Viatris (VTRS) Down 16.4% Since Last Earnings Report?
Mar 29 / Zacks.com - Paid Partner Content
Is Viatris' 5% Dividend Yield Safe?
Mar 21 / MotleyFool.com - Paid Partner Content
3 Healthcare Spinoffs Worth a Look, But 1 Has the Best Long-Term Potential
Mar 26 / MotleyFool.com - Paid Partner Content
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
Mar 20 / Zacks.com - Paid Partner Content
I Own 12 High-Yield Dividend Stocks. Here's the Best of the Bunch.
Mar 25 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close9.56
Today’s open9.66
Day’s range9.60 - 9.70
Volume137,482
Average volume (3 months)8,979,547
Market cap$11.2B
Data as of 2:31pm ET, 03/31/2023

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-12.55%
Earnings growth (next 5 years)-1.60%
Revenue growth (last year)-9.42%
P/E ratio5.6
Price/Sales0.84
Price/Book0.54

Competitors

 Today’s
change
Today’s
% change
CTLTCatalent Inc+1.20+1.86%
----
SRPTSarepta Therapeutics...+2.54+1.87%
----
Data as of 2:33pm ET, 03/31/2023

Financials

Next reporting dateMay 8, 2023
EPS forecast (this quarter)$0.70
Annual revenue (last year)$16.2B
Annual profit (last year)$2.1B
Net profit margin12.85%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Canonsburg, Pennsylvania

Forecasts